These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 399316)

  • 1. Bone loss during oestriol therapy in postmenopausal women.
    Lindsay R; Hart DM; Maclean A; Garwood J; Clark AC; Kraszewski A
    Maturitas; 1979 Jun; 1(4):279-85. PubMed ID: 399316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.
    Lindsay R; Hart DM; Kraszewski A
    Br Med J; 1980 May; 280(6225):1207-9. PubMed ID: 6992927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial effect of oral estriol treatment in postmenopausal women.
    Englund DE; Johansson ED
    Acta Obstet Gynecol Scand; 1980; 59(5):449-51. PubMed ID: 7446012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
    Melis GB; Cagnacci A; Bruni V; Falsetti L; Jasonni VM; Nappi C; Polatti F; Volpe A
    Maturitas; 1996 May; 24(1-2):83-90. PubMed ID: 8794438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
    Christiansen C; Christensen MS; Larsen NE; Transbøl IB
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
    Christiansen C; Rødbro P
    Br J Obstet Gynaecol; 1984 May; 91(5):489-93. PubMed ID: 6722065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause.
    Takahashi K; Okada M; Ozaki T; Kurioka H; Manabe A; Kanasaki H; Miyazaki K
    Hum Reprod; 2000 May; 15(5):1028-36. PubMed ID: 10783346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.
    Christiansen C; Christensen MS; Transbøl I
    Lancet; 1981 Feb; 1(8218):459-61. PubMed ID: 6110089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.
    Lindsay R; Hart DM; Purdie D; Ferguson MM; Clark AS; Kraszewski A
    Clin Sci Mol Med; 1978 Feb; 54(2):193-5. PubMed ID: 340117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen therapy for severe persistent depressions in women.
    Klaiber EL; Broverman DM; Vogel W; Kobayashi Y
    Arch Gen Psychiatry; 1979 May; 36(5):550-4. PubMed ID: 219802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestriol with oestradiol verses oestradiol alone: a comparison of endometrial, symptomatic and psychological effects.
    Padwick ML; Siddle NC; Lane G; Endacott JA; Cooper H; Pryse-Davies J; Whitehead MI
    Br J Obstet Gynaecol; 1986 Jun; 93(6):606-12. PubMed ID: 3524665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.